Sonification Embodied Associations
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03931278 |
Recruitment Status :
Completed
First Posted : April 30, 2019
Last Update Posted : May 27, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Multiple Sclerosis | Other: learning and recall of a sequence of body movements | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 62 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Investigating Auditory Sonification (Melodic and Single Tones) and Visual Real-time Feedback as a Tool for Embodied Associations, and Its Effects on Learning and Balance in Persons With Multiple Sclerosis |
Actual Study Start Date : | December 18, 2018 |
Actual Primary Completion Date : | January 24, 2020 |
Actual Study Completion Date : | January 24, 2020 |

Arm | Intervention/treatment |
---|---|
persons with Multiple Sclerosis (MS) |
Other: learning and recall of a sequence of body movements
The objective of this study to investigate, if learning and recall of a sequence of body movements (steps that realize a pattern on the ground) can be improved by self-produced music (having particular melodic-structures in relation to the pattern), compared to the same sound (a single tone) for each pattern in persons |
Healthy controls |
Other: learning and recall of a sequence of body movements
The objective of this study to investigate, if learning and recall of a sequence of body movements (steps that realize a pattern on the ground) can be improved by self-produced music (having particular melodic-structures in relation to the pattern), compared to the same sound (a single tone) for each pattern in persons |
- accuracy [ Time Frame: week 1 ]Number of correct sequences uttered, total number of sequences, precisions prior to completing three correct trials.
- precision [ Time Frame: week 1 ]Number of correct sequences uttered, total number of sequences, precisions prior to completing three correct trials.
- Inter Step intervals [ Time Frame: week 1 ]The technology used can log time data. Therefore, the inter-step intervals can be calculated from the logged data.
- Inter Stride intervals [ Time Frame: week 1 ]The technology used can log time data. Therefore, the inter stride intervals can be calculated from the logged data.
- step duration on the tile [ Time Frame: week 1 ]The technology used can log time data. Therefore, the total time that each foot is placed on the tiles can be derived.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Time up and Go (TUG) test: 8 sec -- > 21 sec
Exclusion Criteria:
- cognitive impairment hindering the understanding and execution of the experimental procedures,
- pregnancy,
- hearing impairment,
- amusia
- beat deafness,
- colour blindness.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03931278
Belgium | |
University Ghent | |
Ghent, Belgium, 9000 | |
National MS Center Melsbroek | |
Melsbroek, Belgium, 1820 | |
Revalidatie en MS Centrum Overpelt | |
Overpelt, Belgium, 3900 |
Principal Investigator: | peter Feys, prof. dr. | Hasselt University | |
Study Chair: | lousin Moumdjian | Hasselt University |
Responsible Party: | Peter Feys, Principal Investigator, Hasselt University |
ClinicalTrials.gov Identifier: | NCT03931278 |
Other Study ID Numbers: |
SEA-001 |
First Posted: | April 30, 2019 Key Record Dates |
Last Update Posted: | May 27, 2020 |
Last Verified: | May 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Multiple Sclerosis Sclerosis Pathologic Processes Demyelinating Autoimmune Diseases, CNS Autoimmune Diseases of the Nervous System |
Nervous System Diseases Demyelinating Diseases Autoimmune Diseases Immune System Diseases |